Skip to content

Clinical study of Taleswar Ras and Viparitamalla Taila in the management of skin disease

Pharmaceutico-Clinical evaluation of Taleswar Ras and Viparitamalla Taila in the management of Vicharchika - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084222
Enrollment
30
Registered
2025-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L309- Dermatitis, unspecified

Interventions

None listed

Sponsors

Dr Mahanti Jhari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients fulfilling the criteria which are based on symptomatology of vicharchika explained in Ayurvedic classics 2. All types of Eczema 3. Age between 18 to 60 irrespective of sex religion and occupation

Exclusion criteria

Exclusion criteria: 1. Age below 18 years and above 60 years 2.Uncontrolled hypertension, diabetes mellitus and malignancy patients. 3.Undergoing treatment for any other serious illness. 4. Pregnant women and Lactating mothers 5. Women planning for pregnancy 6. Hypothyroidism

Design outcomes

Primary

MeasureTime frame
Relief in Signs and symptoms of Itching, burning sensation, discharge, dryness, discolouration and painTimepoint: 15 days

Secondary

MeasureTime frame
Relief in Signs and symptoms of Itching, burning sensation, discharge, dryness, discolouration and painTimepoint: 15 days

Countries

India

Contacts

Public ContactDrMAHANTI JHARI

Dr N R S Government Ayurvedic College Vijayawada Andhra Pradesh

dr.skovi@gmail.com9491925109

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026